Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

Clinical trial NCT07066982 · RECRUITING

Trial details

NCT number: NCT07066982
Sponsor: Essen Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sarcoma Sarcoma, Kaposi Sarcoma, Ewing Sarcoma,Soft Tissue Sarcoma of Bone and Connective Tissue Sarcoma, Synovial Sarcoma Metastatic Sarcomas, Germinoblastic Sarcoma of Bone

Start date: 2025-05-29
Primary completion: 2027-12-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.